http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2284825-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7ed94ed4fde17a81727552ce83d6abae http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68546fe5c6a684af156bc02f57b11501 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_41bedb3d52b9af0a6c3ecbdc2bc9374a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a52c359426cabd4a1cb09bb16b6054a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7884f2b12475786ca51d52268b626b5f |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 |
| filingDate | 2006-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2006-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcff5d0f035250c76b9e8282b81d84f3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_040d1105f6b43f3b98cca04203d608fe http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c152b8b2f9dc2adec481d1aa7b139d47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_456445fe24bc09fa1f2e566cec39d330 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_918a1a62b233d7a6f24aedcea1d85d51 |
| publicationDate | 2006-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2284825-C1 |
| titleOfInvention | Method for treating abscesses, soft tissue phlegmons |
| abstract | FIELD: medicine, surgical stomatology. n SUBSTANCE: one should apply sodium hypochlorite solution (SHC) as antibacterial, disintoxicative and immunotropic preparation, with the help of which before operative interference one should infiltrate tissue along the periphery of inflammatory infiltrate. After operation, before applying secondary sutures it is necessary to carry out dialysis of purulent wound with SHC. Simultaneously, one should conduct total hemocorrection due to intravenous injection of extracorporally oxidized autoblood for 6 d, daily, correspondingly: 3 ml SHC + 18 ml blood; 6 ml SHC + 15 ml blood; 9 ml SHC + 2 ml blood; 12 ml SHC + 9 ml blood; 15 ml SHC + 6 ml blood; 18 ml SHC + 3 ml blood, and, additionally, 2 h later it is necessary to inject intravenously 0.03%-SHC solution at about 3-4 ml/kg body weight by performing intracorporal blood oxidation. The innovation provides complex local and total disintoxicative, immunotropic and reparative impact at availability of antibioticoresistance that leads to shortened terms of therapy (by 6.9 d, on average) and, also, economy of payments for treating 1 patient at the volume of 2947 rubles. n EFFECT: higher efficiency of therapy. n 2 ex, 1 tbl |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2450794-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2581821-C1 |
| priorityDate | 2006-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 43.